Allergan USA, Inc. et al v. Aurobindo Pharma Ltd. et al
| Allergan USA, Inc., Eden Biodesign, LLC. and Allergan Holdings Unlimited Company |
| MSN Laboratories Private Limited, Alkem Laboratories Limited, Sun Pharmaceutical Industries Limited, Hetero USA Inc., MSN Pharmaceuticals, Inc., Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd., Hetero Labs Limited and Zydus Pharmaceuticals (USA) Inc. |
| 1:2019cv01727 |
| September 13, 2019 |
| US District Court for the District of Delaware |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35:271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 16, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Summons Issued with Magistrate Consent Notice attached as to Alkem Laboratories Limited on 9/16/2019; Aurobindo Pharma Ltd. on 9/16/2019; Aurobindo Pharma USA, Inc. on 9/16/2019; Hetero Labs Limited on 9/16/2019; Hetero USA Inc. on 9/16/2019; MSN Laboratories Private Limited on 9/16/2019; MSN Pharmaceuticals, Inc. on 9/16/2019; Sun Pharmaceutical Industries Limited on 9/16/2019; Zydus Pharmaceuticals (USA) Inc. on 9/16/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sam) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc for Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (sam) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,691,860; 9,115,091; 9,364,489; 9,675,587; 9,789,125; 10,188,632 (sam) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or after 07/31/2019. Date of Expiration of Patent: SEE ATTACHED.Thirty Month Stay Deadline: On or after 11/27/2022. (sam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
| Filing 1 COMPLAINT filed against Alkem Laboratories Limited, Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Eden Biodesign, LLC., Hetero Labs Limited, Hetero USA Inc., MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2730816.) - filed by Allergan Holdings Unlimited Company, Allergan USA, Inc.. (Attachments: #1 Exhibit A-F, #2 Civil Cover Sheet)(sam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
